Biopharmaceutical company ZIOPHARM Oncology, Inc. (ZIOP: Quote) said Monday that the company's President, Chief Operating Officer and Director Richard Bagley is leaving the company and stepping down from the company's board of Directors.
The company also noted that Mark Thornton, Executive Vice President, Government Affairs, Health Policy and Advocacy and Chief Quality Compliance Officer, is also leaving ZIOPHARM to pursue other opportunities.
The company said that the President of Research and Development and Chief Medical Officer, Hagop Youssoufian, will assume the additional responsibility of oversight of all regulatory affairs and clinical operations. Also Caesar Belbel, Executive Vice President, Chief Legal Officer and Secretary, will shoulder the additional responsibility for corporate and business development.
The company also noted that Jason Amello, Executive Vice President and Chief Financial Officer, will continue to be responsible for finance and information technology, and Lynn Ferrucci, Senior Vice President, Human Resources, will continue to oversee human resources.
| || |
| To receive FREE breaking news email alerts for ZIOPHARM Oncology Inc. and others in your portfolio|
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org